Anthim 69604-0204-02
Generic: Obiltoxaximab
- Manufacturer
- Elusys Therapeutics, Inc.
- Dosage Form
- Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 18, 2016
- Listing Expires
- December 31, 2026
- Application
- BLA125509
Need to source Anthim? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Obiltoxaximab | 100 mg/mL |
Drug Class
Anthrax Protective Antigen-directed Antibody [EPC]Anthrax Protective Antigen-directed Antibody Interactions [MoA]Anthrax Protective Antigen-directed Antibody [EPC]
Selected Package
69604-0204-02Selected1 VIAL, SINGLE-USE in 1 CARTON (69604-204-02) / 6 mL in 1 VIAL, SINGLE-USE